Lunaphore Expands Its COMET Portfolio to Become the First Universal, End-to-end Spatial Biology Solution

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, announced the launch of a full expansion of its product offering to provide a universal, end-to-end spatial biology solution, answering the needs of the scientific community from early discovery to late-stage translational and clinical research. This milestone marks the launch of the enhanced version of the company’s revolutionary COMET platform and its comprehensive product suite, which includes a wide range of tools and applications across all research and drug development stages.

 Latest AI Insights : OpenAI Announces Initial support for ChatGPT Plugins

“The spatial biology field is at an inflection point, and Lunaphore is at the forefront of this movement with its radically differentiated technological approach. Since the release of the first COMET™ platform a year ago, we so far observed high customer satisfaction and unmatched traction”

Lunaphore’s multiplex immunofluorescence (mIF) solution portfolio now includes the latest version of the hyperplex, high-throughput, fully automated COMET instrument, providing unmatched scalability and reproducibility without the need to conjugate primary antibodies. The new SPYRE™ Antibody Panel kits, Secondary Antibodies, and an online Panel Builder have been added to the existing offering to help kick-start assay development and enable users with verified biomarkers on COMET.

The product suite is further complemented by HORIZON™, an image analysis software designed and tailored for COMET™ hyperplex images. The software is developed by biologists for biologists to support them in answering fundamental questions about cell profiling and tissue mapping. With Lunaphore’s universal portfolio of precision automation solutions, customers can leverage their existing antibody libraries and decades of know-how on Lunaphore’s platform to scale assays into endless multiplexing possibilities.

“The spatial biology field is at an inflection point, and Lunaphore is at the forefront of this movement with its radically differentiated technological approach. Since the release of the first COMET™ platform a year ago, we so far observed high customer satisfaction and unmatched traction,” said Ata Tuna Ciftlik, CEO at Lunaphore. “We are really excited to launch our comprehensive future-ready solutions. This new COMET™ product suite embeds more than ten years of cutting-edge innovation into powerful tools that accompany our customers, from instant assay creation to streamlined research and analytics. We believe that the COMET ™ product suite is a cornerstone solution that will make spatial biology an everyday tool in laboratories around the globe.”

Read More about Generative AI : Announcing GitHub CoPilotX: World’s Most Powerful Generative AI Pair Programming Tool

“A lot of work in our unit is around preclinical and trial work. We immediately recognized COMET™ as the top platform we were after,” said Dr. Andrew Filer, Head of the Birmingham Tissue Analytics Facility at the University of Birmingham. “We wanted a very high plex, fast, and robust instrument. All of the other platforms that were just coming into the market would have one major failure. The reason we liked COMET™ is that it doesn’t have any significant weaknesses. It covers all the bases, which is really important to us.”

Artificial Intelligence Insights: How Artificial Intelligence is Transforming Customer Service – 7 Use Cases

 [To share your insights with us, please write to sghosh@martechseries.com]